Check out Pro
Top Companies
Recent Trades
Cluster Buys
Sectors
Blog
Join the Insiderviz Pro waitlist
KALA BIO, Inc. (KALA)
All trades on this company by insiders. Hover over bubbles for specific trade details. Drag along the graph for custom price change. Green - Buy, Red - Sell, Orange - Congress Member.
Healthcare
Drug Manufacturers—Specialty & Generic
DATE
INSIDER
COMPANY
OWNED SHARES
SHARES TRADED
PRICE
NET TOTAL
SELL
4 Jan 2024
Iwicki Mark T
CHIEF EXECUTIVE OFFICER, Director, Officer
KALA BIO, Inc.
(KALA)
286,315
-1%
4,539
$6.73
$30,547.47
SELL
4 Jan 2024
Reumuth Mary
CHIEF FINANCIAL OFFICER, Officer
KALA BIO, Inc.
(KALA)
66,136
-1%
1,227
$6.74
$8,269.98
SELL
4 Jan 2024
Bazemore Todd
SEE REMARKS, Officer
KALA BIO, Inc.
(KALA)
0
-100%
1,405
$6.74
$9,469.70
SELL
4 Jan 2024
Kharabi Darius
CHIEF BUSINESS OFFICER, Officer
KALA BIO, Inc.
(KALA)
65,117
-2%
1,385
$6.73
$9,321.05
SELL
4 Jan 2024
Brazzell Romulus K
SEE REMARKS, Officer
KALA BIO, Inc.
(KALA)
91,473
-1%
1,617
$6.74
$10,898.58
SELL
4 Jan 2024
Trachtenberg Eric
SEE REMARKS, Officer
KALA BIO, Inc.
(KALA)
68,066
-1%
1,227
$6.74
$8,269.98
SELL
4 Jan 2023
Trachtenberg Eric
SEE REMARKS, Officer
Kala Pharmaceuticals, Inc.
(KALA)
11,495
-0%
60
$28.55
$1,713.00
SELL
4 Jan 2023
Reumuth Mary
CHIEF FINANCIAL OFFICER, Officer
Kala Pharmaceuticals, Inc.
(KALA)
11,883
-0%
60
$28.54
$1,712.40
SELL
4 Jan 2023
Brazzell Romulus K
SEE REMARKS, Officer
Kala Pharmaceuticals, Inc.
(KALA)
18,536
-0%
73
$28.53
$2,082.69
SELL
4 Jan 2023
Bazemore Todd
SEE REMARKS, Officer
Kala Pharmaceuticals, Inc.
(KALA)
14,835
-0%
62
$28.54
$1,769.48
SELL
4 Jan 2023
Iwicki Mark T
CHIEF EXECUTIVE OFFICER, Director, Officer
Kala Pharmaceuticals, Inc.
(KALA)
45,966
-0%
198
$28.54
$5,650.92
SELL
26 Oct 2022
Bazemore Todd
SEE REMARKS, Officer
Kala Pharmaceuticals, Inc.
(KALA)
2,097
-9%
214
$6.51
$1,393.14
SELL
26 Oct 2022
Brazzell Romulus K
SEE REMARKS, Officer
Kala Pharmaceuticals, Inc.
(KALA)
5,809
-4%
261
$6.51
$1,699.11
SELL
26 Oct 2022
Iwicki Mark T
CHIEF EXECUTIVE OFFICER, Director, Officer
Kala Pharmaceuticals, Inc.
(KALA)
4,464
-11%
561
$6.52
$3,657.72
SELL
26 Oct 2022
Trachtenberg Eric
SEE REMARKS, Officer
Kala Pharmaceuticals, Inc.
(KALA)
2,030
-8%
194
$6.52
$1,264.88
SELL
26 Oct 2022
Reumuth Mary
CHIEF FINANCIAL OFFICER, Officer
Kala Pharmaceuticals, Inc.
(KALA)
2,418
-7%
194
$6.51
$1,262.94
SELL
27 Jun 2022
Trachtenberg Eric
SEE REMARKS, Officer
Kala Pharmaceuticals, Inc.
(KALA)
111,203
-2%
2,613
$0.37
$966.81
SELL
27 Jun 2022
Reumuth Mary
CHIEF FINANCIAL OFFICER, Officer
Kala Pharmaceuticals, Inc.
(KALA)
130,595
-1%
2,613
$0.37
$966.81
SELL
27 Jun 2022
Brazzell Romulus K
SEE REMARKS, Officer
Kala Pharmaceuticals, Inc.
(KALA)
285,201
-1%
3,144
$0.37
$1,163.28
SELL
27 Jun 2022
Bazemore Todd
SEE REMARKS, Officer
Kala Pharmaceuticals, Inc.
(KALA)
115,499
-2%
3,092
$0.37
$1,144.04
SELL
27 Jun 2022
Iwicki Mark T
CHIEF EXECUTIVE OFFICER, Director, Officer
Kala Pharmaceuticals, Inc.
(KALA)
251,183
-3%
7,975
$0.37
$2,950.75
SELL
26 May 2022
RA CAPITAL MANAGEMENT, L.P.
10% Owner
Kala Pharmaceuticals, Inc.
(KALA)
7,039,613
-12%
1,005,686
$0.36
$365,667.40
SELL
23 May 2022
RA CAPITAL MANAGEMENT, L.P.
10% Owner
Kala Pharmaceuticals, Inc.
(KALA)
8,045,299
-26%
2,829,314
$0.53
$1,488,844.20
SELL
3 Jan 2022
Reumuth Mary
CHIEF FINANCIAL OFFICER, Officer
Kala Pharmaceuticals, Inc.
(KALA)
133,208
-2%
2,850
$1.30
$3,705.00
SELL
3 Jan 2022
Brazzell Romulus K
SEE REMARKS, Officer
Kala Pharmaceuticals, Inc.
(KALA)
288,345
-1%
3,504
$1.30
$4,555.20
SELL
3 Jan 2022
Bazemore Todd
SEE REMARKS, Officer
Kala Pharmaceuticals, Inc.
(KALA)
118,591
-2%
3,454
$1.30
$4,490.20
SELL
3 Jan 2022
Iwicki Mark T
CHIEF EXECUTIVE OFFICER, Director, Officer
Kala Pharmaceuticals, Inc.
(KALA)
259,158
-3%
9,518
$1.30
$12,373.40
SELL
3 Jan 2022
Trachtenberg Eric
SEE REMARKS, Officer
Kala Pharmaceuticals, Inc.
(KALA)
113,816
-2%
2,850
$1.30
$3,705.00
SELL
26 Oct 2021
Chen Hongming
CHIEF SCIENTIFIC OFFICER, Officer
Kala Pharmaceuticals, Inc.
(KALA)
204,515
-12%
30,500
$1.81
$55,321.02
SELL
26 Oct 2021
Trachtenberg Eric
SEE REMARKS, Officer
Kala Pharmaceuticals, Inc.
(KALA)
116,666
-7%
9,449
$1.80
$17,008.20
SELL
26 Oct 2021
Reumuth Mary
CHIEF FINANCIAL OFFICER, Officer
Kala Pharmaceuticals, Inc.
(KALA)
136,058
-6%
9,449
$1.80
$17,008.20
SELL
26 Oct 2021
Bazemore Todd
CHIEF OPERATING OFFICER, Officer
Kala Pharmaceuticals, Inc.
(KALA)
122,045
-9%
12,544
$1.80
$22,579.20
SELL
26 Oct 2021
Brazzell Romulus K
CHIEF MEDICAL OFFICER, Officer
Kala Pharmaceuticals, Inc.
(KALA)
291,849
-4%
12,757
$1.80
$22,962.60
SELL
26 Oct 2021
Iwicki Mark T
CHIEF EXECUTIVE OFFICER, Director, Officer
Kala Pharmaceuticals, Inc.
(KALA)
268,676
-9%
27,598
$1.80
$49,676.40
SELL
29 Jun 2021
Chen Hongming
CHIEF SCIENTIFIC OFFICER, Officer
Kala Pharmaceuticals, Inc.
(KALA)
235,015
-2%
5,548
$5.56
$30,846.88
SELL
28 Jun 2021
Chen Hongming
CHIEF SCIENTIFIC OFFICER, Officer
Kala Pharmaceuticals, Inc.
(KALA)
240,563
-1%
2,452
$5.77
$14,148.04
SELL
28 Jun 2021
Brazzell Romulus K
CHIEF MEDICAL OFFICER, Officer
Kala Pharmaceuticals, Inc.
(KALA)
300,962
-0%
3,034
$5.77
$17,506.18
SELL
28 Jun 2021
Trachtenberg Eric
SEE REMARKS, Officer
Kala Pharmaceuticals, Inc.
(KALA)
126,115
-1%
2,452
$5.77
$14,148.04
SELL
28 Jun 2021
Reumuth Mary
CHIEF FINANCIAL OFFICER, Officer
Kala Pharmaceuticals, Inc.
(KALA)
145,507
-1%
2,452
$5.77
$14,148.04
SELL
28 Jun 2021
Bazemore Todd
CHIEF OPERATING OFFICER, Officer
Kala Pharmaceuticals, Inc.
(KALA)
0
-100%
2,911
$5.77
$16,796.47
SELL
28 Jun 2021
Iwicki Mark T
CHIEF EXECUTIVE OFFICER, Director, Officer
Kala Pharmaceuticals, Inc.
(KALA)
296,274
-2%
7,586
$5.77
$43,771.22
BUY
5 Jun 2020
Bazemore Todd
Chief Operating Officer, Officer
Kala Pharmaceuticals, Inc.
(KALA)
42
+100%
42
$7.88
$330.78
BUY
16 Mar 2020
Bazemore Todd
Chief Operating Officer, Officer
Kala Pharmaceuticals, Inc.
(KALA)
10,000
+100%
10,000
$5.75
$57,500.00
BUY
13 Mar 2020
Grunberg Gregory
Director
Kala Pharmaceuticals, Inc.
(KALA)
2,534,854
+100%
2,534,854
$7.89
$19,999,998.00
BUY
13 Mar 2020
Shah Rajeev M.
Director, 10% Owner
Kala Pharmaceuticals, Inc.
(KALA)
10,874,613
+139%
6,337,135
$7.89
$49,999,996.00
BUY
13 Mar 2020
RA CAPITAL MANAGEMENT, L.P.
Director, 10% Owner
Kala Pharmaceuticals, Inc.
(KALA)
10,874,613
+139%
6,337,135
$7.89
$49,999,996.00
BUY
30 May 2019
Rosen Howard B
Director
Kala Pharmaceuticals, Inc.
(KALA)
8,240
+154%
5,000
$5.42
$27,100.00
BUY
5 Oct 2018
Grunberg Gregory
Director
Kala Pharmaceuticals, Inc.
(KALA)
2,877,006
+26%
606,060
$8.25
$4,999,995.00
BUY
3 Oct 2018
Shah Rajeev M.
Director, 10% Owner
Kala Pharmaceuticals, Inc.
(KALA)
4,537,478
+114%
2,424,242
$8.25
$19,999,996.00
BUY
3 Oct 2018
RA CAPITAL MANAGEMENT, LLC
Director, 10% Owner
Kala Pharmaceuticals, Inc.
(KALA)
4,537,478
+114%
2,424,242
$8.25
$19,999,996.00
BUY
8 Feb 2018
ORBIMED ADVISORS LLC
10% Owner
Kala Pharmaceuticals, Inc.
(KALA)
3,447,840
+0%
25,000
$12.93
$323,250.00
BUY
2 Feb 2018
ORBIMED ADVISORS LLC
10% Owner
Kala Pharmaceuticals, Inc.
(KALA)
3,422,840
+1%
37,840
$14.73
$557,383.20
BUY
31 Jan 2018
ORBIMED ADVISORS LLC
10% Owner
Kala Pharmaceuticals, Inc.
(KALA)
3,385,000
+11%
362,240
$15.00
$5,433,371.50
BUY
26 Jan 2018
ORBIMED ADVISORS LLC
10% Owner
Kala Pharmaceuticals, Inc.
(KALA)
3,022,760
+2%
72,760
$14.97
$1,089,306.80
BUY
12 Jan 2018
ORBIMED ADVISORS LLC
10% Owner
Kala Pharmaceuticals, Inc.
(KALA)
2,950,000
+9%
257,285
$14.88
$3,828,990.50
BUY
10 Jan 2018
ORBIMED ADVISORS LLC
10% Owner
Kala Pharmaceuticals, Inc.
(KALA)
2,692,715
+9%
240,484
$13.28
$3,192,710.00
BUY
25 Jul 2017
ORBIMED ADVISORS LLC
10% Owner, See Remarks
Kala Pharmaceuticals, Inc.
(KALA)
2,375,279
+15%
319,333
$15.00
$4,789,995.00
BUY
25 Jul 2017
Longitude Capital Partners II, LLC
10% Owner
Kala Pharmaceuticals, Inc.
(KALA)
2,270,946
+10%
215,000
$15.00
$3,225,000.00
BUY
25 Jul 2017
RA CAPITAL MANAGEMENT, LLC
Director
Kala Pharmaceuticals, Inc.
(KALA)
2,113,236
+33%
533,333
$15.00
$7,999,995.00
BUY
25 Jul 2017
Grunberg Gregory
Director
Kala Pharmaceuticals, Inc.
(KALA)
2,270,946
+10%
215,000
$15.00
$3,225,000.00
BUY
25 Jul 2017
Shah Rajeev M.
Director
Kala Pharmaceuticals, Inc.
(KALA)
2,113,236
+33%
533,333
$15.00
$7,999,995.00
BUY
20 Jul 2017
CDK ASSOCIATES, L.L.C.
10% Owner
Kala Pharmaceuticals, Inc.
(KALA)
215,000
+100%
215,000
$15.00
$3,225,000.00
Home